Abstract
Breast cancer is one of the most common and lethal cancers in women. As a hub gene involved in a diversity of tumors, the ubiquitin-conjugating enzyme H10 (UbcH10), may also play some roles in the genesis and development of breast cancer. In the current study, we found that the expression of UbcH10 was up-regulated in some breast cancer tissues and five cell lines. We established a dual drug resistant cell line MCF-7/EPB (epirubicin)/TXT (docetaxel) and a lentiviral system expressing UbcH10 shRNA to investigate the effects of UbcH10 knockdown on the chemosensitivity of MCF-7/EPB/TXT cells to epirubicin and docetaxel. The knockdown of UbcH10 inhibited the proliferation of both MCF-7 and MCF-7/EPB/TXT cells, due to the G1 phase arrest in cell cycle. Furthermore, UbcH10 knockdown increased the sensitivity of MCF-7/EPB/TXT cells to epirubicin and docetaxel and promoted the apoptosis induced by these two drugs. Protein detection showed that, in addition to inhibiting the expression of Ki67 and cyclin D1, UbcH10 RNAi also impaired the increased BCL-2 and MDR-1 expression levels in MCF-7/EPB/TXT cells, which may contribute to abating the drug resistance in the breast cancer cells. Our research in the current study demonstrated that up...Continue Reading
References
Dec 1, 1990·The Biochemical Journal·J D Hayes, C R Wolf
Mar 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·F M TownsleyJ V Ruderman
Feb 9, 2000·Japanese Journal of Cancer Research : Gann·K ShirakawaK Okumura
Oct 16, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Maria Teresa BerlingieriAlfredo Fusco
Nov 29, 2008·Cancer Science·Takeo FujitaHiroyoshi Doihara
Jan 13, 2010·The Journal of Cell Biology·Janine H van ReeJan M van Deursen
Mar 6, 2012·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Ida PerrottaGiuseppe Donato
Jul 5, 2012·Journal of Cancer Research and Clinical Oncology·Liming ZhaoBing Li
Nov 5, 2013·International Journal of Breast Cancer·Hamid Reza MirzaeiParastoo Hajian
Dec 3, 2013·Breast Cancer Research and Treatment·Xiaosong ChenKunwei Shen
Dec 19, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G G StegerUNKNOWN Austrian Breast and Colorectal Study Group (ABCSG)
Dec 24, 2013·The International Journal of Biochemistry & Cell Biology·Chanlu XieQihan Dong
Jul 25, 2014·Molecular Pharmaceutics·Isabella PedriniChiara Riganti
Aug 1, 2014·Biochimica Et Biophysica Acta·Mafalda VideiraMaria Alexandra Brito
Aug 2, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·N V VardhiniG Sudhakar
Aug 3, 2014·Expert Opinion on Therapeutic Targets·Patricia B GauleMichael J Duffy
Aug 3, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Wentao LiBaoping Zhai
Aug 3, 2014·Breast Cancer Research and Treatment·Dena A JerjeesEmad A Rakha
Aug 3, 2014·Carcinogenesis·Zhiyu WangJianping Chen
Aug 3, 2014·The Journal of Biological Chemistry·Xin Zhao, Susan A Rotenberg
Citations
Oct 19, 2017·Cancer Biomarkers : Section a of Disease Markers·Si SunShengrong Sun
Mar 28, 2019·Bioscience Reports·Yu XiongZhenyu Yin
Nov 16, 2017·Oncotarget·Xingjie MaWeibo Qi
Sep 10, 2020·Diagnostics·Pei-Feng LiuBor-Hwang Kang
Mar 21, 2020·International Journal of Molecular Sciences·Ivan PrestaGiuseppe Donato
Dec 22, 2016·Oncology Reports·Hao XiLi-Ming Zhao
May 16, 2018·PeerJ·Yu-Chun ChangLi-Li Hsiao
Jan 30, 2019·Journal of Oncology·Yan WuJiwei Guo
Jan 6, 2018·Cancer Biology & Therapy·Yan ZhangChang Liu
Sep 8, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Tao QinMan Li
Jul 3, 2021·Cells·Quyen Thu BuiPeter Chang-Whan Lee